Reductions in systolic BP (-4.3 mmHg) were also observed, but did not achieve significance, possibly due to insufficient statistical power.
← all excerpts
Impact of a clinical pharmacist on a cardiovascular surrogate endpoint: a pilot study.
1
—
—
Reductions in systolic BP (-4.3 mmHg) were also observed, but did not achieve significance, possibly due to insufficient statistical power.